Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2017 / Jan / The Right Angle
Glaucoma Research & Innovations

The Right Angle

Why anterior segment imaging is my gold standard method for diagnosing and monitoring angle-closure glaucoma

By Hiroshi Ishikawa 1/12/2017 1 min read

Share

Most of you reading this probably view gonioscopy as the gold standard method for determining if an eye has an occludable angle. I would argue that anterior segment imaging through ultrasound biomicroscopy (UBM) and/or optical coherence tomography (OCT) is better – and has several clear advantages. Here are my reasons why. First, anterior segment imaging is objective: you can make quantitative assessments through measuring the angle, anterior chamber depth, corneal thickness, and so on. Second, several publications have shown that imaging is better than gonioscopy in terms of reproducibility and agreement: intra-observer repeatability is higher with imaging (1) and there is a high agreement between gonioscopy and UBM when both are performed in a darkened room (2). Third, anterior segment imaging can be a great patient education tool – patients can see their angle closure and response to treatment.

Although I think UBM and OCT are both great, it’s difficult to say which is best; they each have their own benefits. As OCT is a non-contact method, it can be performed in post-operative eyes as soon as a day after surgery – obviously UBM isn’t recommended for this. OCT also has a higher axial resolution than UBM – 5 µm versus 25 µm. On the other hand, you can’t always see the scleral spur with OCT, but it can be located consistently with UBM. Penetration is also better with UBM, meaning that it can help diagnose cases of plateau iris. Whilst you can visualize the angle and the flat iris with OCT, you may not be able to see the ciliary body processes, but with UBM, you can see the process very clearly, and you can also assess whether there is space in the sulcus. So to diagnose plateau iris, you need to use UBM – you would sometimes struggle to accurately diagnose these cases with gonioscopy alone even with indentation. To me, using anterior segment imaging instead of gonioscopy is a no-brainer. It’s more precise, it offers greater consistency with angle assessment and it represents the true angle. I also find that the cross-sectional view is more robust when variations in the iris profile are present. We know that the agreement between gonioscopy and anterior imaging is high (2), meaning that sensitivity and specificity of the two are similar. So why not choose the method with higher reproducibility and precision?

References

  1. P Campbell et al., “Repeatability and comparison of clinical techniques for anterior chamber angle assessment”, Ophthalmic Physiol Opt, 35, 170–178 (2015). PMID: 25761580. Y Barkana et al., “Agreement between gonioscopy and ultrasound biomicroscopy in detecting iridotrabecular apposition”, Arch Ophthalmol, 125, 1331–1335 (2007). PMID: 17923539.

About the Author(s)

Hiroshi Ishikawa

Hiroshi Ishikawa is a Professor of Ophthalmology at New York University School of Medicine, New York, NY, USA

More Articles by Hiroshi Ishikawa

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: